Clinical Trial

Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

Name: Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus — clinical trial record (NCT06227221)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to investigate the therapeutic effect and safety of Sorafenib in T1DM patients.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-01-17; most recent amendment 2026-02-09.

Trial Details

NCT Number	NCT06227221
Lead Sponsor	Second Xiangya Hospital of Central South University
Conditions	Type 1 Diabetes
Enrollment	10 participants
Start Date	2026-02
Primary Completion	2028-10 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-02-12